UNSPSC 85814515: Introduction of liquid brachytherapy radioisotope into female reproductive, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into female reproductive, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P804

UNSPSC 85814515, Introduction of liquid brachytherapy radioisotope into female reproductive via natural or artificial opening endoscopic, is a Commodity code that shows no relevant recent state and local procurement activity; the recent opportunities posted under this code are unrelated to the procedural medical intervention the code nominally describes.

The posted opportunities span virtual urgent care services (Inland Empire Health Plan, California, RFI due October 31, 2026), generic medical services (DeKalb County, Georgia, RFP due November 12, 2026), and comprehensive elderly care programs (Nevada Health Authority PACE operations, RFP due December 10, 2026). None of these solicitations target brachytherapy, oncology procedures, or radiation-based interventional services. The mismatch suggests either miscoding at the issuing-body level or a data classification error in the opportunities block. State and local procurement offices rarely solicit brachytherapy services—this is predominantly a hospital-system line item or capital equipment acquisition, not a standalone contract category. The code appears dormant for discrete state and local contracting; pursue only if your firm operates under oncology or radiation services contracts that state customers have tagged this way in error.